Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
595 SEK | +0.85% | +2.15% | +10.32% |
May. 23 | Camurus' Rare Growth Disorder Drug Accepted for Review in EU | MT |
May. 23 | Camurus Receives EMA Acceptance of MAA Filing for Octreotide SC Depot for the Treatment of Acromegaly | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.32% | 3.27B | |
+43.64% | 754B | |
+39.18% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
+11.72% | 217B | |
-1.76% | 216B | |
+0.03% | 163B | |
+6.13% | 164B |
- Stock Market
- Equities
- CAMX Stock
- News Camurus AB
- Camurus' New Drug Application for Acromegaly Treatment Accepted by US FDA